Abraxane and pulmonary embolism Patient Reports February 11, 2012

Abraxane Side Effects Report #4977154-1
Abraxane side effect was reported by a Physician from UNITED STATES on Mar 15, 2006. Female patient, 66 years of age, weighting 135.0 lb, was diagnosed with non-small cell lung cancer and was treated with Abraxane. After drug was administered, patient experienced the following side effects: pulmonary embolism . Abraxane dosage: unknown. During the same period patient was treated with PLAVIX, ZOCOR, ANZEMET, DEXAMETHASONE, MARINOL, LEXAPRO, XANAX. Patient died on 02/26/2006.

Abraxane Side Effects Report #4978555-8
Abraxane side effect was reported by a Physician from UNITED STATES on Mar 15, 2006. Female patient, 66 years of age, weighting 135.0 lb, was diagnosed with non-small cell lung cancer and was treated with Abraxane. After drug was administered, patient experienced the following side effects: pulmonary embolism . Abraxane dosage: unknown. During the same period patient was treated with PLAVIX, ZOCOR, ANZEMET, DEXAMETHASONE, MARINOL, LEXAPRO, XANAX. Patient died on 02/26/2006.

Abraxane Side Effects Report #4982439-9
Abraxane side effect was reported by a Physician from UNITED STATES on Apr 14, 2006. Female patient, 66 years of age, weighting 135.0 lb, was diagnosed with non-small cell lung cancer, lung neoplasm malignant and was treated with Abraxane. After drug was administered, patient experienced the following side effects: acute myocardial infarction, pulmonary embolism . Abraxane dosage: (190 MG, D1, D8, Q21D), INTRAVENOUS DRIP. During the same period patient was treated with CARBOPLATIN, PLAVIX, ZOCOR, ANZEMET, DEXAMETHASONE, MARINOL, LEXAPRO, XANAX. Patient died on 02/26/2006.

Abraxane Side Effects Report #6105670-8
Abraxane side effect was reported by a Health Professional from UNITED STATES on Mar 04, 2009. Female patient, weighting 121.3 lb, was diagnosed with neoplasm malignant and was treated with Abraxane. After drug was administered, patient experienced the following side effects: haemoglobin decreased, pulmonary embolism . Abraxane dosage: 410 MG D1/CYCLE 042. During the same period patient was treated with VANDETANIB, PANCRELIPASE, ATENOLOL, ALPRAZOLAM, COMPAZINE, LEXAPRO, PROBIOTICS. Patient recovered.


Abraxane Side Effects Report #6105728-3
Abraxane side effect was reported by a Health Professional from UNITED STATES on Mar 04, 2009. Female patient, weighting 121.3 lb, was diagnosed with neoplasm malignant and was treated with Abraxane. After drug was administered, patient experienced the following side effects: haemoglobin decreased, pulmonary embolism . Abraxane dosage: 410 MG D1/CYCLE 042. During the same period patient was treated with VANDETANIB, PANCRELIPASE, ATENOLOL, ALPRAZOLAM, COMPAZINE, LEXAPRO, PROBIOTICS. Patient recovered.

Abraxane Side Effects Report #6091356-5
Abraxane side effect was reported by a Health Professional from UNITED STATES on Feb 19, 2009. Female patient, weighting 127.4 lb, was diagnosed with metastatic neoplasm and was treated with Abraxane. After drug was administered, patient experienced the following side effects: fatigue, neutropenia, pulmonary embolism . Abraxane dosage: 168 MG D1,D8, D15/CYCLE 042. During the same period patient was treated with VANDETANIB, FENTANYL TRANSDERMAL SYSTEM, ADVIL, MEGACE, TOPROL. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5638956-1
Abraxane side effect was reported by a Health Professional from UNITED STATES on Feb 25, 2008. Female patient, weighting 152.0 lb, was diagnosed with malignant melanoma and was treated with Abraxane. After drug was administered, patient experienced the following side effects: cough, pulmonary embolism , white blood cell count decreased. Abraxane dosage: 150MG/M^2 QWEEKLY, REST 1 WK, IV DRIP. During the same period patient was treated with BEVACIZUMAB, CHERTUSSIN AC, NYSTATIN, LEVAQUIN. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5638958-5
Abraxane side effect was reported by a Health Professional from UNITED STATES on Feb 25, 2008. Female patient, weighting 152.0 lb, was diagnosed with malignant melanoma and was treated with Abraxane. After drug was administered, patient experienced the following side effects: chest discomfort, cough, dyspnoea, pulmonary embolism , white blood cell count decreased. Abraxane dosage: 150MG/M^2 QWEEKLY, REST 1 WK INTRAVENOUS DRIP. During the same period patient was treated with BEVACIZUMAB, CHERTUSSIN AC, NYSTATIN. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #4967382-3
Abraxane side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 07, 2006. Female patient, weighting 135.0 lb, was diagnosed with lung neoplasm malignant and was treated with Abraxane. After drug was administered, patient experienced the following side effects: acute myocardial infarction, depression , dyspnoea, pulmonary embolism . Abraxane dosage: 190 MG D1, D8 Q 21 D IV. During the same period patient was treated with CARBOPLATIN, PLAVIX, ZOCOR, ANZEMENT, DEXAMETHASONE, MARINOL, LEXAPRO, XANAX. Patient died on 02/26/2006.


Abraxane Side Effects Report #5065858-4
Abraxane side effect was reported by a Physician from UNITED STATES on July 11, 2006. Female patient, 61 years of age, weighting 154.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: atelectasis, coordination abnormal, gait disturbance, neurotoxicity, pleural effusion, pulmonary embolism . Abraxane dosage: 221 MG, EVERY 21 DAYS, INTRAVENOUS DRIP. During the same period patient was treated with XELODA, NEURONTIN, COUMADIN, LASIX, POTASSIUM, EFFEXOR, MIDODRINE HYDROCHLORIDE. Patient was hospitalized and became disabled. Patient recovered.